Gerjo J. de Knegt

Statistics

Publications

Citations

934

H-Index

Active since

2009

Affiliations

Erasmus MC(Current)

Erasmus University Rotterdam

National Institute for Public Health and the Environment

Radboud University Nijmegen

Radboud University Medical Center

Gerjo J. de Knegt is an author at Erasmus MC specializing in mycobacterium tuberculosis infection, tuberculosis pharmacotherapy, and infectious diseases.

Publications per year

2009–2019

Publications

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

Jurriaan E.M. de Steenwinkel, Gerjo J. de Knegt, M. T. ten Kate et al. · Journal of Antimicrobial Chemotherapy · 2010 · 165 citations

Medicine, Pharmacology, Pharmacotherapy +15

A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain–Barré syndrome

Rogier Louwen, Deborah Horst-Kreft, Angela G. E. M. de Boer et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2012 · 152 citations · Full text

Life Sciences, Immunology, Microbiology +13

Drug Susceptibility of<i>Mycobacterium tuberculosis</i>Beijing Genotype and Association with MDR TB

Jurriaan E.M. de Steenwinkel, Marian T. ten Kate, Gerjo J. de Knegt et al. · Emerging infectious diseases · 2012 · 95 citations · Full text

Medicine, Pharmacology, Pharmacogenetics +13

Optimization of the Rifampin Dosage to Improve the Therapeutic Efficacy in Tuberculosis Treatment Using a Murine Model

Jurriaan E.M. de Steenwinkel, Rob E. Aarnoutse, Gerjo J. de Knegt et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 94 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis

Gerjo J. de Knegt, Oskar Bruning, Marian T. ten Kate et al. · Tuberculosis · 2012 · 67 citations

Life Sciences, Infectious Diseases, Microbiology +14

1–5 of 21